North America Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
The North America doxorubicin market is expected to grow from US$ 617.61 million in 2022 to US$ 888.89 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2022 to 2028.
Various countries have introduced missions and programs for rapid and effective cancer treatment. For example, in 2020, the National Comprehensive Cancer Control Program provided funding, guidance, and technical assistance to help programs implement cancer prevention and control plans. In 2016, the US government launched Cancer Moonshot with three ambitious goals. It is about accelerating scientific discoveries related to cancer, facilitating collaboration, and improving data sharing. Moreover, in February 2022, the Cancer Moonshot Project highlighted new goals of reducing cancer mortality by at least 50% over the next 25 years and provided information about enhancing cancer patients' and their families' lives. Furthermore, government funding for cancer prevention in various countries offers significant growth opportunities for the market. In June 2020, the National Institutes of Health granted nearly US$ 3.5 million to the University of Missouri School of Medicine to study a pre-treatment for chemotherapy that could protect cancer patients from therapy-induced heart problems. Thus, with rising cancer prevalence and increasing government support as funding, guidance, and assistance, emerging countries are providing significant growth opportunities to manufacturers operating in the doxorubicin drug market across the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America doxorubicin market. The North America doxorubicin market is expected to grow at a good CAGR during the forecast period.
North America Doxorubicin Market Revenue and Forecast to 2028 (US$ Million) 
Get more information on this report :
North America Doxorubicin Market Segmentation
The North America doxorubicin market is segmented based on drug formulation, application, distribution channel, and country. Based on drug formulation, the North America doxorubicin market is bifurcated into lyophilized powder and doxorubicin injection. The lyophilized powder segment dominated the market in 2022. Based on application, the North America doxorubicin market is segmented into breast cancer, kidney cancer, liver cancer, sarcoma, ovarian cancer, lung cancer, leukemia, multiple myeloma, and others. The breast cancer segment dominated the market in 2022. Based on distribution channel, the North America doxorubicin market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market in 2022. Based on country, the North America doxorubicin market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US dominated the market in 2022.
Accord Healthcare; Baxter International Inc.; Cipla Inc.; Dr. Reddy's Laboratories; Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.); Meiji Holdings Co., Ltd.; Novartis AG; Pfizer Inc.; Sun Pharmaceutical Industries Ltd; and Zydus Cadila are among the leading companies in the North America doxorubicin market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Doxorubicin Market – By Drug Formulation
1.3.2 North America Doxorubicin Market – By Application
1.3.3 North America Doxorubicin Market – By Distribution Channel
1.3.4 North America Doxorubicin Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Doxorubicin Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Doxorubicin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.1.2 Increasing Preference for Chemotherapy
5.2 Market Restraints
5.2.1 Potential Side-effects Associated with Doxorubicin
5.3 Market Opportunities
5.3.1 Increasing Government Funding, Guidance, and Technical Assistance for Cancer Prevention
5.4 Future Trends
5.4.1 Increasing Approval of Generic Products
5.5 Impact Analysis
6. Doxorubicin Market– North America Analysis
6.1 North America Doxorubicin Market Revenue Forecast and Analysis
7. North America Doxorubicin Market Analysis – By Drug Formulation
7.1 Overview
7.2 North America Doxorubicin Market Share, By Drug Formulation 2022 & 2028 (%)
7.3 Lyophilized Powder
7.3.1 Overview
7.3.2 Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
7.4 Doxorubicin Injection
7.4.1 Overview
7.4.2 Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8. North America Doxorubicin Market Analysis – By Application
8.1 Overview
8.2 North America Doxorubicin Market Share, By Application 2022 & 2028 (%)
8.3 Breast Cancer
8.3.1 Overview
8.3.2 Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.4 Kidney Cancer
8.4.1 Overview
8.4.2 Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.5 Liver Cancer
8.5.1 Overview
8.5.2 Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.6 Sarcoma
8.6.1 Overview
8.6.2 Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.7 Ovarian Cancer
8.7.1 Overview
8.7.2 Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.8 Lung Cancer
8.8.1 Overview
8.8.2 Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.9 Leukemia
8.9.1 Overview
8.9.2 Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.10 Multiple Myeloma
8.10.1 Overview
8.10.2 Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
8.11 Others
8.11.1 Overview
8.11.2 Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9. North America Doxorubicin Market Analysis – By Disribution Channel
9.1 Overview
9.2 North America Doxorubicin Market Share, By Disribution Channel 2022 & 2028 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
10. North America Doxorubicin Market Analysis – By Country
10.1 Overview
10.1.1 North America: Doxorubicin Market, by Country, 2022 & 2028 (%)
10.1.1.1 US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.1.1.4 US: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 US: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.1.2 Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.1.2.4 Canada: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 Canada: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.1.3 Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Doxorubicin Market, by Drug Formulation, 2019–2028 (US$ Million)
10.1.1.3.4 Mexico: Doxorubicin Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 Mexico: Doxorubicin Market, by Distribution Channel, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Accord Healthcare
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Cipla Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Dr. Reddy's Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Meiji Holdings Co., Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pfizer Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sun Pharmaceutical Industries Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Baxter International Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Zydus Cadila
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Doxorubicin Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. US Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Doxorubicin Market, by Drug Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Doxorubicin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Doxorubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 11. Organic Developments Done By Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Doxorubicin Market Segmentation
Figure 2. North America Doxorubicin Market Segmentation, By Country
Figure 3. North America Doxorubicin Market Overview
Figure 4. North America Doxorubicin Market, By Drug Formulation
Figure 5. North America Doxorubicin Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. North America Doxorubicin Market Impact Analysis Of Driver And Restraints
Figure 8. North America Doxorubicin Market– Revenue Forecast and Analysis
Figure 9. North America Doxorubicin Devices Market Share, By Drug Formulation 2022 & 2028 (%)
Figure 10. North America Lyophilized Powder: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 11. North America Doxorubicin Injection: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 12. North America Doxorubicin Devices Market Share, By Application 2022 & 2028 (%)
Figure 13. North America Breast Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 14. North America Kidney Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 15. North America Liver Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 16. North America Sarcoma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 17. North America Ovarian Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 18. North America Lung Cancer: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 19. North America Leukemia: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 20. North America Multiple Myeloma: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 21. North America Others: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 22. North America Doxorubicin Devices Market Share, By Disribution Channel 2022 & 2028 (%)
Figure 23. North America Hospital Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 24. North America Retail Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 25. North America Online Pharmacy: Doxorubicin Market Revenue and Forecast To 2028 (US$ Million)
Figure 26. North America: Doxorubicin Market, By Key Country – Revenue (2022) (US$ Million)
Figure 27. North America: Doxorubicin Market, by Country, 2022 & 2028 (%)
Figure 28. US: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Canada: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Mexico: Doxorubicin Market – Revenue and Forecast to 2028 (US$ Million)
- Accord Healthcare
- Baxter International Inc.
- Cipla Inc.
- Dr. Reddy's Laboratories
- Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)
- Meiji Holdings Co., Ltd.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America doxorubicin market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America doxorubicin market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the doxorubicin market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution